Description
Telacebec is an imidazopyridine compound with high bactericidal activity. It may even be effective against extensively drug-resistant tuberculosis.
Telacebec
Product ID T174441
Cas No. 1334719-95-7
Purity ≥98%
| Product Unit Size | Cost | Quantity | Stock |
|---|
Product Info
| Cas No. | 1334719-95-7 |
|---|---|
| Purity | ≥98% |
| Formula | C29H28ClF3N4O2 |
| Formula Wt. | 557.0 |
| Chemical Name | 6-chloro-2-ethyl-N-[[4-[4-[4-(trifluoromethoxy)phenyl]piperidin-1-yl]phenyl]methyl]imidazo[1,2-a]pyridine-3-carboxamide |
| IUPAC Name | 6-chloro-2-ethyl-N-[[4-[4-[4-(trifluoromethoxy)phenyl]piperidin-1-yl]phenyl]methyl]imidazo[1,2-a]pyridine-3-carboxamide |
| Synonym | Q203, IAP6 |
| Appearance | White powder |
Shipping and Storage
| Store Temp | 4°C |
|---|---|
| Ship Temp | Ambient |
Downloads
| MSDS | |
|---|---|
| Info Sheet |
References
Malik I, Cizmarik J, Kovac G, et al. Telacebec (Q203): Is there a novel effective and safe anti-tuberculosis drug on the horizon? Ceska Slov Farm. 2021 Winter;70(5):164-171. PMID: 35114793.
Lee B, Pethe K. Telacebec: an investigational antibacterial for the treatment of tuberculosis (TB). Expert Opin Investig Drugs. 2022 Feb;31(2):139-144. PMID: 35034512.
Komm O, Almeida D, Converse P, et al. Impact of dose, duration, and immune status on efficacy of ultrashort telacebec regimens in mouse models of Buruli ulcer. Antimicrob Agents Chemother. 2021 Oct 18;65(11):e0141821. PMID: 34460302.